| Scleral Allografting and Amniotic Membrane Transplantation With Fibrin Glue in the Management of Scleromalacia. |
|
Byeong Hee Lee, Hong Jae Mun, Young Jeung Park, Kyoo Won Lee |
|
Cheil Eye Hospital, Daegu, Korea. eyepark9@dreamwiz.com |
| 공막연화증에 대하여 조직접합제를 이용한 동종공막이식술과 양막이식술의 임상성적 |
|
이병희ㆍ문홍재ㆍ박영정ㆍ이규원 |
|
Cheil Eye Hospital, Daegu, Korea |
|
|
| Abstract |
PURPOSE
To examine the effects, complications, and safeties of sclera allograft and amniotic membrane transplantation with fibrin glue as surgical treatment methods for scleromalacia. METHODS: The study included 14 eyes of 14 scleromalacia patients who needed surgical treatment. Among them, seven eyes of seven patients whose scleral defect was small (<6 mm) were operated on using only fibrin glue and no suturing, while seven eyes of seven patients whose defect was large (>6 mm) were operated on using fibrin glue and minimum suturing. Amniotic membrane transplantation was performed at the site of the conjunctival defect. RESULTS: In all of the cases, the results of grafting were successful throughout the follow-up period, which was 14.6+/-4.4 months, on average (ranging from 12 to 27 months). No particular complication was observed during the follow-up period after using fibrin glue. CONCLUSIONS: For scleromalacia patients, sclera allograft and amniotic membrane transplantation were performed using fibrin glue. The grafted sclera survived successfully, allowing this treatment modality to be considered an effective and safe option without complications. |
| Key Words:
AMT;Fibrin glue;Scleral graft;Scleromalacia |
|
PDF Links
Full text via DOI
Download Citation
